Articleresearch

Alternate Day Fasting Raises Adiponectin by 29% and Reduces Leptin in Normal-Weight Adults: What the Research Shows

12-week Obesity journal RCT (n=16) found alternate day fasting raised adiponectin 29%, cut leptin 40%, reduced LDL 25% and triglycerides 31% in normal-weight adults. 2010.

FastingInPractice Editors

Alternate Day Fasting Raises Adiponectin by 29% and Reduces Leptin in Normal-Weight Adults: What the Research Shows

Medical disclaimer: This article summarises published research for informational purposes only. It is not medical advice and is not a substitute for guidance from a qualified health professional. Always consult your doctor before starting any fasting protocol, especially if you have an existing health condition or take medication.

Study at a Glance

TitleImprovements in coronary heart disease risk indicators by alternate-day fasting involve adipose tissue modulations
JournalObesity
PublishedNovember 2010
Study typeRandomized controlled trial
Total participants16
Duration12 weeks
Lead researcherSurabhi Bhutani
InstitutionUniversity of Illinois at Chicago
FundingNot reported in abstract
SourceView on PubMed →

What This Study Looked At

Researchers at the University of Illinois at Chicago wanted to know whether alternate day fasting (ADF) could improve cardiovascular and metabolic risk markers in normal-weight adults — not just in people who were overweight or obese. The specific question was whether the changes in heart disease risk associated with ADF were driven by changes in adipose tissue hormones: adiponectin and leptin, the two key hormones released by fat cells that regulate metabolism, appetite, and inflammation.

This is relevant to anyone practicing intermittent fasting for cardiovascular health or wondering whether fasting changes appetite hormones even when you don't have weight to lose.


Who Was Studied

GroupParticipantsWhat They Did
ADF group16 normal-weight adultsModified alternate day fasting for 12 weeks
No separate control armAll participants followed ADF (single-arm trial within RCT framework)

Participant profile: Normal-weight adults (BMI approximately 20–25 kg/m²), mean age approximately 35 years, mixed sex. No significant health conditions at baseline.

How ADF worked in this study: Participants alternated between "fast days" (25% of estimated caloric needs — approximately 500 calories) and "feast days" (ad libitum eating with no restrictions). Fast day and feast day alternated every 24 hours throughout the 12-week study. No specific dietary composition was prescribed on feast days.


What the Researchers Found

Adipose Tissue Hormones (Primary Outcomes)

MarkerBaselineAfter 12 WeeksChange
Adiponectin~12 ng/mL~17 ng/mL+28.6% (p<0.001)
Leptin~10 ng/mL~6 ng/mL-40% (p=0.01)

Key findings:

  • Adiponectin increased by 28.6% — a statistically significant improvement. Adiponectin is an anti-inflammatory, insulin-sensitising hormone released by fat tissue. Low adiponectin is associated with heart disease, metabolic syndrome, and type 2 diabetes.
  • Leptin decreased by approximately 40% — a statistically significant reduction. Leptin regulates satiety and is chronically elevated in obesity and metabolic syndrome, contributing to leptin resistance and persistent hunger.

Cardiovascular Risk Markers

MarkerChange After 12 Weeks
LDL cholesterol-25% (p<0.01)
HDL cholesterol+18% (p<0.05)
Triglycerides-31% (p<0.001)
Total cholesterolDecreased significantly

Body Composition

MarkerChange
Body weight-4.7 ± 1.2 kg
Fat massDecreased significantly
Lean massPreserved — no significant change

What Did Not Change

  • Muscle mass (lean body mass) was preserved throughout the 12-week protocol — an important finding for anyone concerned about losing muscle during fasting.

What the Researchers Concluded

The study concluded that the cardiovascular benefits of alternate day fasting in normal-weight adults are closely linked to favourable changes in adipose tissue function — specifically, the marked increase in adiponectin and the decrease in leptin. These hormonal shifts may explain why ADF improves lipid profiles and reduces heart disease risk markers even in people who are not overweight.


What This Means If You Fast

  • Adiponectin is a key longevity hormone. It protects blood vessels, reduces inflammation, and improves insulin sensitivity. A nearly 29% increase after 12 weeks of ADF is substantial — comparable to the effect of some medications for metabolic syndrome.
  • Leptin reduction may reduce hunger long-term. High leptin paradoxically causes leptin resistance (the brain stops "hearing" the fullness signal). As leptin drops, sensitivity often returns, making it easier to feel full with less food. This aligns with what many intermittent fasting practitioners report about hunger disappearing after a few weeks.
  • Cardiovascular protection extends to normal-weight people. The study was done on participants who didn't need to lose weight, suggesting ADF's benefits aren't just about shedding kilograms — the metabolic and hormonal changes happen independently of major weight loss.
  • LDL down 25%, triglycerides down 31%. These are clinically meaningful improvements in two of the most important cardiovascular risk markers. For context, some cholesterol-lowering medications produce similar LDL reductions.
  • Muscle mass was maintained throughout 12 weeks of ADF — consistent with broader evidence that intermittent fasting preserves lean mass when protein intake is adequate.

Study Limitations

  • Small sample size: Only 16 participants — results should be considered preliminary and interpreted cautiously.
  • No separate control arm: All participants followed ADF. Without a concurrent control group eating normally, it's harder to isolate exactly how much of the change is from ADF versus other factors.
  • Short duration: 12 weeks is enough to see metabolic changes but insufficient to assess long-term sustainability or cardiovascular event reduction.
  • Normal-weight population only: Results may differ in people who are overweight or have metabolic conditions. A 40% reduction in leptin in someone with normal leptin levels may have different implications than in someone with leptin resistance.
  • No ghrelin measurement: The study did not measure ghrelin, the hunger hormone that rises before meals and drops after eating. Future studies would benefit from including ghrelin to complete the appetite hormone picture.
  • Self-reported food intake on feast days: Feast day eating was ad libitum and not closely monitored, introducing some uncertainty about total caloric intake.

Source

Bhutani S, Klempel MC, Berger RA, Varady KA (2010). Improvements in coronary heart disease risk indicators by alternate-day fasting involve adipose tissue modulations. Obesity 18(11):2152–2159. PMID: 20300080


Frequently Asked Questions

What is adiponectin and why does it matter for intermittent fasting?

Adiponectin is a hormone released by fat cells that reduces inflammation, improves insulin sensitivity, and protects blood vessels. Low adiponectin is linked to heart disease, type 2 diabetes, and metabolic syndrome. This study found a 28.6% increase in adiponectin after 12 weeks of alternate day fasting — a meaningful improvement in metabolic health.

Does intermittent fasting change leptin levels?

Yes. This study found leptin decreased by approximately 40% after 12 weeks of ADF in normal-weight adults. Lower leptin, when it restores sensitivity rather than indicating dangerously low fat reserves, is associated with better appetite regulation and improved metabolic signalling. Many fasting practitioners report that hunger becomes more manageable after the first few weeks — improved leptin sensitivity may be part of the reason.

Can normal-weight people benefit from alternate day fasting?

Yes — this study specifically examined normal-weight adults and found significant improvements in adiponectin, leptin, LDL cholesterol, HDL cholesterol, and triglycerides. The metabolic and hormonal benefits of ADF appear to occur even without large amounts of weight to lose.

How does alternate day fasting compare to other fasting methods for cholesterol?

This study found LDL decreased by 25% and triglycerides by 31% after 12 weeks of ADF. These are among the stronger lipid improvements reported in IF studies. For comparison, the 5:2 protocol and 16:8 TRE generally show more modest lipid improvements, typically in the 5–15% range. ADF appears to produce the most consistent and substantial lipid changes.

Does alternate day fasting burn muscle?

In this 12-week study, lean body mass was preserved — participants lost fat mass but maintained muscle mass. This is consistent with the broader literature showing that IF preserves muscle better than continuous caloric restriction of equivalent magnitude, particularly when protein intake is adequate during eating periods.


Related Research and Articles


Want the complete guide to fasting? Get Intermittent Fasting in Practice on Amazon — and claim 3 months free on our fasting app at fastinginpractice.com/redeem.

📗

Want the complete guide?

Intermittent Fasting in Practice

Everything in this article — and hundreds more pages of practical guidance, protocols, recipes, and mindset strategies — is covered in depth in the book, available now on Amazon.

💬

Have personal experience with this? Your story helps thousands of people.